HIV Citation List: July 22 - August 4, 2009
Pubmed citations:
1. Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones. Zhao XZ, Maddali K, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR Jr. Bioorg Med Chem Lett. 2009 May 15;19(10):2714-7. Epub 2009 Mar 28. PMID: 19364649
2. Vicriviroc, a CCR5 receptor antagonist for the potential treatment of HIV infection. Klibanov OM. Curr Opin Investig Drugs. 2009 Aug;10(8):845-59. PMID: 19649929
3. Synthesis and Biological Evaluation of C-5 Methyl Substituted 4-Arylthio and 4-Aryloxy-3-Iodopyridin-2(1H)-one Type Anti-HIV Agents (dagger). Guillemont J, Benjahad A, Oumouch S, Decrane L, Palandjian P, Vernier D, Queguiner L, Andries K, de Béthune MP, Hertogs K, Grierson DS, Nguyen CH. J Med Chem. 2009 Jul 31. [Epub ahead of print] PMID: 19645483
4. Small molecule targets Env for ER-associated protein degradation and inhibits HIV-1 propagation. Jejcic A, Daniels R, Goobar-Larsson L, Hebert DN, Vahlne A. J Virol. 2009 Jul 29. [Epub ahead of print] PMID: 19640982
5. An allosteric mechanism for inhibiting HIV-1 integrase with a small molecule. Kessl JJ, Eidahl JO, Shkriabai N, Zhao Z, McKee CJ, Hess S, Burke TR, Kvaratskhelia M. Mol Pharmacol. 2009 Jul 28. [Epub ahead of print] PMID: 19638533
6. Synthesis and Anti-HIV-1 Activity of 1-Substiuted 6-(3-Cyanobenzoyl) and [(3-Cyanophenyl)fluoromethyl]-5-ethyl-uracils. Loksha YM, Pedersen EB, Loddo R, La Colla P. Arch Pharm (Weinheim). 2009 Jul 27. [Epub ahead of print] PMID: 19637180
7. A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa. Zhang GQ, Sun J, Wang HX, Ng TB. Acta Biochim Pol. 2009 Jul 28. [Epub ahead of print] PMID: 19636442
8. 9-aminoacridine Inhibition of HIV-1 Tat Dependent Transcription. Guendel I, Carpio L, Easley R, Van Duyne R, Coley W, Agbottah E, Dowd C, Kashanchi F, Kehn-Hall K. Virol J. 2009 Jul 24;6(1):114. [Epub ahead of print] PMID: 19630958
9. Human immunodeficiency type 1 (HIV-1) protease inhibitors block the cell-to-cell HIV-1 endocytosis in dendritic cells. Muratori C, Ruggiero E, Sistigu A, Bona R, Federico M. J Gen Virol. 2009 Jul 22. [Epub ahead of print] PMID: 19625465
10. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine. Quevedo MA, Briñón MC. Antiviral Res. 2009 Aug;83(2):103-11. Epub 2009 Apr 5. PMID: 19549583
11. Quantitative structure-activity relationship study on the anti-HIV-1 activity of novel 6-naphthylthio HEPT analogs. Riahi S, Pourbasheer E, Dinarvand R, Ganjali MR, Norouzi P. Chem Biol Drug Des. 2009 Aug;74(2):165-72. Epub 2009 Jun 22. PMID: 19549086
12. N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors. Petrocchi A, Jones P, Rowley M, Fiore F, Summa V. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4245-9. Epub 2009 May 29. PMID: 19523819
13. Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strains. Pan C, Cai L, Lu H, Qi Z, Jiang S. J Virol. 2009 Aug;83(16):7862-72. Epub 2009 Jun 3. PMID: 19493996
14. Antiviral activity of indole derivatives. Giampieri M, Balbi A, Mazzei M, La Colla P, Ibba C, Loddo R. Antiviral Res. 2009 Aug;83(2):179-85. Epub 2009 May 13. PMID: 19445965
15. Screening of Tanzanian Medicinal Plants against Plasmodium falciparum and Human Immunodeficiency Virus. Maregesi S, Van Miert S, Pannecouque C, Feiz Haddad MH, Hermans N, Wright CW, Vlietinck AJ, Apers S, Pieters L. Planta Med. 2009 Aug 3. [Epub ahead of print] PMID: 19653145
ISI Web of Knowledge citations:
16. Retention of Metabolites of 2 ',3 '-Didehydro-3 '-Deoxy-4 '-Ethynylthymidine, a Novel Anti-Human Immunodeficiency Virus Type 1 Thymidine Analog, in Cells. Wang, X; Tanaka, H; Baba, M; Cheng, YC. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009; 53(8): 3317-3324.
17. Small Molecule CCR5 and CXCR4-Based Viral Entry Inhibitors for Anti-HIV Therapy Currently in Development.Kazmierski, WM; Gudmundsson, KS; Piscitelli, SC. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 2009; 42: 301-320.
18. Peptides derived from HIV-1 protease inhibit Vif activity. Wexselblatt, E; Britan-Rosich, E; Hutoran, M; Nowarski, R; Katzhendler, J; Kotler, M. AMINO ACIDS, 2009; 37: 64.
19. New indolic non-peptidic HIV protease inhibitors from (S)-glycidol: synthesis and preliminary biological activity. Chiummiento, L; Funicello, M; Lupattelli, P; Tramutola, F; Campaner, P. TETRAHEDRON, 2009; 65(31): 5984-5989.
20. SYNTHESIS AND ANTI-HIV ACTIVITY OF 4 '-MODIFIED CYCLOPENTENYL PYRIMIDINE C-NUCLEOSIDES. Liu, LJ; Hong, JH. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2009; 28(4): 303-314.
21. HIV-1 assembly and its inhibition. Krausslich, HG; Bartonova, V; Carlson, LA; Muller, B; Morales, I; Grunewald, K; Briggs, J. FEBS JOURNAL, 2009; 276: 57.
22. Design, structure and activity of potent HIV protease inhibitors based on inorganic polyhedral metallacarboranes. Pokorna, J; Brynda, J; Kozisek, M; Cigler, P; Lepsik, M; Plesek, J; Gruner, B; Oberwinkler, H; Krausslich, HG; Kral, V; Konvalinka, J; Rezacova, P. FEBS JOURNAL, 2009; 276: 78.
23. Pyrophosphate analogs as inhibitors of phosphorolytic activity of HIV-1 reverse transcriptase. Yanvarev, D; Smirnova, O; Ivanov, A; Tatarintsev, A; Kukhanova, M. FEBS JOURNAL, 2009; 276: 352-353.
24. Synthesis of 6-sulfamoyl-4-oxoquinoline-3-carboxylic acid derivatives as integrase antagonists with anti-HIV activity. Luo, ZG; Zeng, CC; Yang, LF; He, HQ; Wang, CX; Hu, LM. CHINESE CHEMICAL LETTERS, 2009; 20(7): 789-792.
25. Anti-HIV Activity of LXR Agonists. Grant, AM; Morrow, MP; Dubrovsky, L; Kashanchi, F; Sviridov, D; Bukrinsky, M. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009; 29(7): E73.